KEGG: seh:SeHA_C3663
The p-hydroxybenzoic acid efflux pump subunit AaeA in Salmonella heidelberg is a membrane fusion protein (MFP) that functions as part of a multicomponent efflux system responsible for extruding p-hydroxybenzoic acid and potentially other antimicrobial compounds from bacterial cells. This protein plays a critical role in the efflux mechanism, forming part of the complex that spans from the inner membrane to the outer membrane of the bacterial cell. The AaeA protein requires interaction with other components to form a functional efflux system that contributes to antimicrobial resistance in S. heidelberg. Similar to other membrane fusion proteins in Gram-negative bacteria, AaeA likely facilitates the connection between the inner membrane transporter and the outer membrane component, allowing for the efficient extrusion of substrates across both membranes .
The AaeA efflux pump subunit differs from other efflux components in Salmonella in several key ways:
Substrate specificity: While multidrug efflux systems like AcrAB-TolC can export a wide range of antibiotics and other compounds, the AaeA-containing system appears to have more specificity for aromatic compounds like p-hydroxybenzoic acid .
Structural characteristics: AaeA belongs to the membrane fusion protein (MFP) family, which differentiates it from inner membrane transporters (like AcrB) or outer membrane channels (like TolC) .
Genetic regulation: AaeA expression is positively regulated by AaeR, making its regulation distinct from other efflux systems that may be controlled by different regulatory proteins such as those controlling AcrAB expression .
Function in resistance: Unlike the AcrAB-TolC system, which plays a dominant role in fluoroquinolone resistance in Salmonella, the AaeA system appears to have a more specialized role in resistance to specific compounds .
Unlike other well-characterized efflux systems such as AcrAB-TolC, which has been demonstrated to have critical roles in both antimicrobial resistance and virulence across multiple Salmonella serovars, the specific contributions of AaeA to S. heidelberg pathogenesis and antimicrobial resistance profiles are still being investigated .
Isolation of recombinant AaeA from Salmonella heidelberg typically involves a multi-step process combining molecular cloning, heterologous expression, and protein purification techniques:
Gene amplification: The aaeA gene is PCR-amplified from Salmonella heidelberg genomic DNA using specific primers designed based on the gene sequence.
Cloning: The amplified gene is inserted into an appropriate expression vector containing:
A strong promoter (such as T7)
Appropriate affinity tags (typically N-terminal or C-terminal His-tag)
Selection markers for stable maintenance
Expression: The recombinant construct is transformed into a suitable host (commonly E. coli BL21(DE3) or similar strains) for protein expression under optimized conditions .
Cell disruption: Bacterial cells are harvested and lysed using methods appropriate for membrane proteins:
Mechanical disruption (sonication, French press)
Enzymatic lysis (lysozyme treatment)
Detergent-based extraction methods
Purification: The recombinant protein is purified using:
Immobilized metal affinity chromatography (IMAC) utilizing the His-tag
Size exclusion chromatography for further purification
Ion exchange chromatography if needed
Quality control: The purified protein undergoes:
Each batch of purified recombinant AaeA should be tested for endotoxin content if intended for functional studies, and protein stability assessments should be performed to determine optimal storage conditions .
The AaeA efflux pump subunit contributes to antimicrobial resistance in Salmonella heidelberg through several mechanisms:
Direct extrusion of antimicrobial compounds: As part of a multicomponent efflux system, AaeA helps facilitate the export of p-hydroxybenzoic acid and potentially certain antibiotics from the bacterial cell, reducing their intracellular concentration below inhibitory levels .
Cooperative function: Similar to how AcrA works with AcrB and TolC, AaeA requires interaction with other components (likely AaeB) to form a complete and functional efflux system. This multiprotein complex spans both membranes of the Gram-negative cell envelope to effectively remove toxic compounds .
Specialized resistance: While the AcrAB-TolC system provides broad resistance to multiple antimicrobials in Salmonella, the AaeA-containing system may provide specialized resistance to specific compounds that are not efficiently extruded by other efflux systems .
Potential contribution to adaptive resistance: Similar to other efflux systems in Salmonella, the AaeA pump may contribute to adaptive resistance to antimicrobial compounds such as biocides or disinfectants, impacting bacterial survival in poultry production environments .
Research indicates that efflux pump-mediated resistance mechanisms in Salmonella often work in concert with other resistance mechanisms, such as target modifications or enzymatic inactivation of antimicrobials, to produce high-level resistance phenotypes. The specific antimicrobial agents that the AaeA-containing system can extrude in S. heidelberg warrant further investigation, particularly in the context of antimicrobial resistance genes (ARGs) harbored on mobile genetic elements .
The relationship between AaeA expression and antimicrobial susceptibility profiles in clinical isolates of Salmonella heidelberg shows several important patterns:
A comparative analysis of antimicrobial susceptibility between wild-type strains and isogenic mutants with deleted aaeA would provide definitive evidence for the specific contribution of this efflux component to resistance profiles. Current evidence from studies of S. heidelberg isolates suggests that strains with ARGs on plasmids persist longer in environmental conditions like poultry litter, potentially increasing the risk of transmission and treatment failures .
The expression of the aaeA gene in Salmonella heidelberg is regulated through several molecular mechanisms:
Transcriptional regulation by AaeR:
Operon structure:
Environmental stress responses:
Expression increases under conditions of:
Exposure to aromatic acids
Specific antimicrobial compounds
Environmental stressors that trigger general stress response pathways
Global regulation:
Multiple global regulators may influence aaeA expression including:
Stress-response sigma factors
Two-component systems that sense environmental conditions
Regulatory networks that control antimicrobial resistance genes
Plasmid-associated regulation:
Understanding these regulatory mechanisms is essential for developing strategies to combat antimicrobial resistance. By targeting the regulatory pathways that control efflux pump expression, researchers may be able to enhance bacterial susceptibility to existing antimicrobials .
The optimal expression systems for producing functional recombinant AaeA protein from Salmonella heidelberg require careful consideration of several factors:
Expression host selection:
E. coli BL21(DE3): Offers high protein yields and lacks certain proteases
E. coli C41(DE3) or C43(DE3): Specialized strains for membrane protein expression
Homologous expression in attenuated Salmonella strains: Provides native post-translational modifications
Vector system optimization:
pET-based vectors: Allow tight control of expression with T7 promoter
pBAD vectors: Provide tunable expression with arabinose-inducible promoters
Low-copy vectors: May improve folding of membrane proteins like AaeA
Fusion tags selection:
Expression conditions:
Temperature: Lower temperatures (16-25°C) often improve proper folding
Induction timing: Mid-log phase induction typically yields better results
Media composition: Specialized media with osmolytes or chaperone-inducing compounds
Membrane extraction methods:
Detergent selection: Critical for maintaining native conformation
Commonly effective detergents include:
n-Dodecyl β-D-maltoside (DDM)
n-Octyl β-D-glucopyranoside (OG)
Digitonin for gentler extraction
The choice between prokaryotic and eukaryotic expression systems should be guided by the experimental goals. For structural studies requiring large amounts of protein, E. coli-based systems optimize yield. For functional studies, maintaining the native conformation is paramount, potentially favoring homologous expression in Salmonella strains .
Researchers can assess the functional activity of recombinant AaeA in vitro through several complementary approaches:
Reconstitution assays:
Proteoliposome-based transport assays: Purified AaeA is reconstituted with its partner proteins (like AaeB) into artificial liposomes
Substrate accumulation/efflux is measured using:
Fluorescent substrates with real-time monitoring
Radiolabeled compounds with scintillation counting
LC-MS/MS quantification for non-labeled substrates
Binding assays:
Surface plasmon resonance (SPR): Measures direct binding between AaeA and:
Other efflux pump components
Potential substrate molecules
Inhibitor compounds
Isothermal titration calorimetry (ITC): Quantifies thermodynamic parameters of binding interactions
Structural integrity assessment:
Circular dichroism (CD) spectroscopy: Evaluates secondary structure content
Differential scanning calorimetry (DSC): Determines thermal stability
Limited proteolysis: Assesses proper folding
Complementation studies:
AaeA-deficient strains reconstituted with the recombinant protein
Restoration of efflux activity measured by:
Minimum inhibitory concentration (MIC) determinations
Fluorescent dye accumulation assays
Growth inhibition zone assays
Protein-protein interaction analysis:
Co-immunoprecipitation with partner proteins
Bacterial two-hybrid systems
Cross-linking studies followed by mass spectrometry
A standardized in vitro assay for p-hydroxybenzoic acid efflux should include both negative controls (AaeA-deficient systems) and positive controls (native efflux systems) to validate results. Researchers should also consider how the presence of affinity tags might affect protein function and include tag-cleaved versions in their experimental design .
The most effective methodological approaches for studying AaeA interactions with other efflux pump components combine biochemical, biophysical, genetic, and computational techniques:
In vitro protein-protein interaction assays:
Pull-down assays: Using tagged recombinant AaeA to identify interacting partners
Surface plasmon resonance (SPR): Measuring real-time binding kinetics between purified components
Microscale thermophoresis (MST): Detecting interactions in solution with minimal sample consumption
Förster resonance energy transfer (FRET): Monitoring proximity between fluorescently labeled components
Structural biology approaches:
X-ray crystallography: Determining high-resolution structures of protein complexes
Cryo-electron microscopy: Visualizing larger assemblies in near-native states
Hydrogen-deuterium exchange mass spectrometry (HDX-MS): Mapping interaction interfaces
Nuclear magnetic resonance (NMR): Analyzing dynamic interactions in solution
Genetic and in vivo methods:
Bacterial two-hybrid systems: Screening for protein interactions in living cells
In vivo cross-linking followed by co-immunoprecipitation: Capturing native complexes
Suppressor mutation analysis: Identifying compensatory mutations that restore function
Fluorescence microscopy with tagged proteins: Visualizing co-localization in bacterial cells
Systems biology approaches:
Computational methods:
Molecular docking: Predicting binding modes between AaeA and partner proteins
Molecular dynamics simulations: Analyzing stability and dynamics of protein complexes
Sequence co-evolution analysis: Identifying potentially interacting residues
When studying membrane protein complexes like efflux pumps, maintaining the native membrane environment is critical. Therefore, approaches that preserve the lipid environment (such as native nanodiscs or styrene-maleic acid copolymer extraction) often yield more physiologically relevant results than traditional detergent-based methods .
The structure-function relationship of AaeA in Salmonella heidelberg compared to other bacterial species reveals both conserved features and species-specific adaptations:
Conserved structural domains:
Membrane-proximal domain: Anchors the protein to the inner membrane
α-hairpin domain: Forms coiled-coil structures that extend into the periplasmic space
Lipoyl domain: Mediates interactions with outer membrane components
These core domains show high structural conservation across Gram-negative bacteria
Species-specific variations:
Sequence homology: AaeA from S. heidelberg shares approximately 85-90% sequence identity with E. coli AaeA but lower identity with other species
Substrate binding pocket: Subtle amino acid substitutions may alter substrate specificity profiles
Surface-exposed loops: Show greater sequence divergence, potentially affecting interactions with species-specific partners
Functional conservation and divergence:
Core mechanism: The basic function as a membrane fusion protein is preserved across species
Regulatory integration: AaeA regulation may be integrated into different species-specific regulatory networks
Environmental adaptation: Sequence variations likely reflect adaptation to different ecological niches and exposure to different antimicrobials
Comparative analysis with other membrane fusion proteins:
AaeA vs. AcrA (in AcrAB-TolC system): Despite functional similarity, they show distinct structural features affecting substrate range
AaeA vs. MdtA (in MdtABC system): Both function in efflux systems but with different partner selectivity
These differences highlight evolutionary divergence in efflux pump architecture
The structural adaptations in AaeA across different species likely contribute to the varying antimicrobial resistance profiles observed in different bacterial pathogens. Understanding these structure-function relationships provides valuable insights for developing species-specific efflux pump inhibitors as potential therapeutic adjuvants .
The role of AaeA in Salmonella heidelberg virulence and persistence in host environments involves multiple interconnected mechanisms:
Host colonization and persistence:
Environmental adaptation: AaeA-containing efflux systems may contribute to bacterial survival in:
Low pH environments (stomach, phagosome)
Bile salt-rich conditions (intestine)
Antimicrobial peptide exposure in host tissues
Similar to the TolC-dependent systems that are required for colonization in the avian gut, AaeA may play a role in S. heidelberg persistence in poultry
Stress response integration:
Oxidative stress: Efflux systems help manage oxidative damage caused by host immune responses
Metabolic adaptation: AaeA may facilitate export of toxic metabolic by-products during host colonization
This stress response role parallels findings that efflux pump disruption affects expression of pathogenesis genes
Evasion of host defense mechanisms:
Antimicrobial peptide resistance: Efflux pumps export host-derived antimicrobial peptides
Immune modulator export: Some efflux systems export molecules that interfere with host immunity
These mechanisms could contribute to S. heidelberg survival during infection
Interaction with the host microbiome:
Competition advantage: AaeA-mediated export of inhibitory compounds may provide competitive advantages
Biofilm formation: Efflux systems are often important for biofilm development and maintenance
Mobile genetic element acquisition: As seen with plasmid and bacteriophage transfer in S. heidelberg strains
Environmental persistence:
Experimental evidence from related Salmonella serovars demonstrates that efflux pump components contribute to virulence and host colonization. For example, TolC is required for S. Typhimurium colonization in chicks, although the specific contribution of AcrAB varies between studies. The potential role of AaeA in S. heidelberg virulence merits investigation through similar colonization models .
Mobile genetic elements significantly influence the distribution and evolution of aaeA in Salmonella heidelberg populations through multiple mechanisms:
Horizontal gene transfer dynamics:
Plasmid-mediated transfer: Plasmids carrying aaeA or its regulatory elements can spread between bacterial populations
Transposon-facilitated mobilization: Insertion sequences may mobilize aaeA between genomic locations
Bacteriophage-mediated transduction: As observed in S. heidelberg strains where some clones acquired lysogenic bacteriophage from other populations
Co-selection with antimicrobial resistance genes:
Physical linkage: When aaeA is located near other ARGs on mobile elements, selection for one resistance determinant maintains the entire element
Functional complementarity: Efflux systems often work synergistically with other resistance mechanisms
This is exemplified in S. heidelberg strains where:
Evolutionary adaptation mechanisms:
Increased copy number: S. heidelberg clones persisting in litter carried higher copy numbers of Col plasmids than ancestral strains
Acquisition of novel genetic material: Some S. heidelberg strains acquired bacteriophage from other populations
These genetic adaptations likely provide selective advantages in specific environments
Population-level impacts:
Clonal expansion: Successful strains with advantageous mobile genetic elements show clonal expansion
Strain displacement: Strains with enhanced fitness due to mobile element acquisition may outcompete others
Differential persistence: S. heidelberg strains with plasmid-borne ARGs demonstrated enhanced environmental persistence
The data from broiler litter studies demonstrates that S. heidelberg strains harboring transmissible plasmids carrying AmpC-like beta-lactamase genes persisted longer even without antibiotic selection pressure. This suggests that plasmid acquisition provides fitness advantages beyond simple antimicrobial resistance, potentially involving regulatory effects on efflux systems like those containing AaeA .
The substrate specificity of AaeA-containing efflux systems compared to other efflux pumps in Salmonella reveals important functional distinctions:
Substrate profile comparison:
| Efflux System | Primary Substrates | Antimicrobial Classes | Biocides/Dyes | Role in Resistance |
|---|---|---|---|---|
| AaeA-containing | p-hydroxybenzoic acid, aromatic acids | Limited antibiotic spectrum | Some phenolic compounds | Specialized resistance |
| AcrAB-TolC | Diverse hydrophobic/amphipathic compounds | Fluoroquinolones, β-lactams, macrolides, tetracyclines | Triclosan, acriflavine, crystal violet | Dominant MDR mechanism |
| MdtABC | Bile salts, novobiocin | Limited antibiotic spectrum | Some metal ions | Specialized resistance |
| EmrAB | Hydrophobic compounds | Nalidixic acid, thiolactomycin | CCCP, organomercurials | Supplementary resistance |
| MdfA | Diverse hydrophobic compounds | Chloramphenicol, fluoroquinolones | Quaternary ammonium compounds | Supplementary resistance |
Structural basis for specificity:
Complementary resistance coverage:
When AcrAB is absent or inhibited, other efflux systems including AaeA-containing pumps may provide compensatory resistance
In fluoroquinolone-resistant S. Typhimurium strains without AcrB, AcrEF becomes overexpressed through IS element insertions
Similar compensatory mechanisms may involve AaeA-containing systems under specific selection conditions
Synergistic substrate interactions:
The specialized nature of AaeA-containing efflux systems compared to the broader substrate profile of AcrAB-TolC suggests they may have evolved to address specific niche challenges rather than providing broad multidrug resistance. This specialized role may be particularly important in environments containing aromatic compounds or specific antimicrobials not efficiently extruded by other efflux systems .
Several emerging technologies hold promise for enhancing our understanding of AaeA function in Salmonella heidelberg:
Advanced structural biology approaches:
Cryo-electron tomography: Visualizing efflux pumps in their native membrane environment
Micro-electron diffraction (MicroED): Determining structures from microcrystals of membrane proteins
Single-particle cryo-EM: Resolving structures of complete efflux assemblies at near-atomic resolution
These methods could reveal the detailed structure of AaeA in complex with its partner proteins
High-throughput functional genomics:
Advanced imaging technologies:
Super-resolution microscopy: Visualizing the spatial organization of AaeA in living cells
Single-molecule tracking: Following the dynamics of individual AaeA molecules in real-time
Correlative light and electron microscopy (CLEM): Connecting molecular localization with ultrastructural context
Innovative biochemical approaches:
Computational and systems biology tools:
Molecular dynamics simulations: Modeling AaeA dynamics at atomistic resolution
Machine learning for substrate prediction: Identifying potential new substrates based on molecular features
Protein structure prediction using AlphaFold2: Generating accurate models of AaeA and its complexes
Microfluidics and organ-on-chip technologies:
Bacterial infection models in microfluidic devices: Studying AaeA function during host-pathogen interactions
Gradient generators: Analyzing AaeA response to changing antibiotic concentrations
Single-cell analysis: Examining heterogeneity in AaeA expression and function
The integration of these technologies could provide unprecedented insights into how AaeA contributes to antimicrobial resistance, environmental persistence, and virulence in Salmonella heidelberg, potentially leading to new strategies for controlling this pathogen .
Developing strategies to specifically target AaeA-containing efflux systems to combat antimicrobial resistance requires a multifaceted approach:
Structure-based inhibitor design:
Rational drug design targeting:
AaeA-specific binding interfaces with partner proteins
Unique structural features not present in human proteins
Allosteric sites that disrupt efflux pump assembly
Fragment-based screening to identify initial chemical scaffolds
Computational optimization to enhance specificity and potency
Disruption of pump assembly:
Genetic and regulatory interventions:
Combination therapy approaches:
| Strategy | Mechanism | Potential Advantages | Development Considerations |
|---|---|---|---|
| Efflux inhibitor + antibiotic | Blocks efflux to increase intracellular antibiotic concentration | Restores efficacy of existing antibiotics | Requires careful toxicity assessment |
| Dual-target inhibitors | Single molecule targets both AaeA and antibiotic target | Reduces likelihood of resistance development | Complex medicinal chemistry challenges |
| Sequential therapy | Initial efflux inhibition followed by antibiotic treatment | Potential for enhanced efficacy | Requires precise timing and dosing |
| Anti-virulence + efflux inhibition | Combines pathogenicity reduction with enhanced antibiotic efficacy | Multifaceted approach to infection control | Need to establish clinical endpoints |
Exploitation of fitness costs:
Environmental management strategies:
The development of successful AaeA-targeting strategies requires consideration of potential resistance mechanisms and cross-talk between different efflux systems. Salmonella harboring plasmid-borne resistance determinants have demonstrated enhanced persistence, suggesting that effective control strategies must address both chromosomal and plasmid-encoded components of resistance .